<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">27124583</PMID>
        <DateCompleted>
            <Year>2017</Year>
            <Month>10</Month>
            <Day>24</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>01</Month>
            <Day>15</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2041-4889</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>7</Volume>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>04</Month>
                        <Day>28</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cell death &amp; disease</Title>
                <ISOAbbreviation>Cell Death Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e2209</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/cddis.2016.102</ELocationID>
            <Abstract>
                <AbstractText>Glioblastoma (GBM) is one of the most aggressive types of cancer with limited therapeutic options and unfavorable prognosis. Stemness and non-classical epithelial-to-mesenchymal transition (ncEMT) features underlie the switch from normal to neoplastic states as well as resistance of tumor clones to current therapies. Therefore, identification of ligand/receptor systems maintaining this privileged state is needed to devise efficient cancer therapies. In this study, we show that the expression of CD95 associates with stemness and EMT features in GBM tumors and cells and serves as a prognostic biomarker. CD95 expression increases in tumors and with tumor relapse as compared with non-tumor tissue. Recruitment of the activating PI3K subunit, p85, to CD95 death domain is required for maintenance of EMT-related transcripts. A combination of the current GBM therapy, temozolomide, with a CD95 inhibitor dramatically abrogates tumor sphere formation. This study molecularly dissects the role of CD95 in GBM cells and contributes the rational for CD95 inhibition as a GBM therapy.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Drachsler</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kleber</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mateos</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Volk</LastName>
                    <ForeName>K</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mohr</LastName>
                    <ForeName>N</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cirovic</LastName>
                    <ForeName>B</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cell Differentiation and Tumorigenesis, Max Delbrück Center, Berlin 13125, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tüttenberg</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, Clinical Center Idar-Oberstein, Idar-Oberstein 55743, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gieffers</LastName>
                    <ForeName>C</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Apogenix GmbH, Heidelberg 69120, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sykora</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Apogenix GmbH, Heidelberg 69120, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wirtz</LastName>
                    <ForeName>C R</ForeName>
                    <Initials>CR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, University Hospital Ulm, Günzburg 89312, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mueller</LastName>
                    <ForeName>W</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuropathology, University Hospital Leipzig, Leipzig 04103, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Synowitz</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, Charité, University Medicine Berlin, Berlin 13353, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, Campus Kiel, Kiel 24105, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Martin-Villalba</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">0000-0002-9405-8910</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>04</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Cell Death Dis</MedlineTA>
            <NlmUniqueID>101524092</NlmUniqueID>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018906">Antineoplastic Agents, Alkylating</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C491901">FAS protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D019014">fas Receptor</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>7GR28W0FJI</RegistryNumber>
                <NameOfSubstance UI="D003606">Dacarbazine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.1.137</RegistryNumber>
                <NameOfSubstance UI="D058543">Class Ia Phosphatidylinositol 3-Kinase</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>F333OQQ9UV</RegistryNumber>
                <NameOfSubstance UI="C574675">APG101</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>YF1K15M17Y</RegistryNumber>
                <NameOfSubstance UI="D000077204">Temozolomide</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D018906" MajorTopicYN="N">Antineoplastic Agents, Alkylating</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001932" MajorTopicYN="N">Brain Neoplasms</DescriptorName>
                <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058543" MajorTopicYN="N">Class Ia Phosphatidylinositol 3-Kinase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003606" MajorTopicYN="N">Dacarbazine</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004357" MajorTopicYN="N">Drug Synergism</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058750" MajorTopicYN="N">Epithelial-Mesenchymal Transition</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015972" MajorTopicYN="Y">Gene Expression Regulation, Neoplastic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005909" MajorTopicYN="N">Glioblastoma</DescriptorName>
                <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>
                <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014411" MajorTopicYN="N">Neoplastic Stem Cells</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D061251" MajorTopicYN="N">Primary Cell Culture</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018874" MajorTopicYN="N">Spheroids, Cellular</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000077204" MajorTopicYN="N">Temozolomide</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019014" MajorTopicYN="N">fas Receptor</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2016</Year>
                <Month>02</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2016</Year>
                <Month>03</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2016</Year>
                <Month>03</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>4</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>4</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>10</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27124583</ArticleId>
            <ArticleId IdType="pii">cddis2016102</ArticleId>
            <ArticleId IdType="doi">10.1038/cddis.2016.102</ArticleId>
            <ArticleId IdType="pmc">PMC4855647</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Cell. 2008 Mar;13(3):235-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18328427</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2015 Nov 26;527(7579):472-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26560033</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13820-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19666588</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Cell. 2010 Jan 19;17(1):98-110</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20129251</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2008 May 16;133(4):704-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18485877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO Rep. 2008 Jun;9(6):582-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18483486</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2008 Oct 23;455(7216):1061-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18772890</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Stem Cell. 2009 May 8;4(5):440-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19427293</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2009;4(5):e5498</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19430532</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Stem Cell. 2009 Aug 7;5(2):178-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19664992</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO J. 2004 Aug 4;23(15):3175-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15272306</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1989 Jul 21;245(4915):301-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2787530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 1991 Jul 26;66(2):233-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1713127</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2004 Nov 18;432(7015):396-401</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15549107</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16199517</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2007 May 1;67(9):4010-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17483311</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 2010 Feb 16;102(4):639-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20087353</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2010 Feb 26;32(2):240-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20153221</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Stem Cell. 2010 May 7;6(5):421-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20452317</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2010 May 27;465(7297):492-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20505730</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Stem Cell. 2010 Dec 3;7(6):744-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21112568</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Cell. 2010 Dec 14;18(6):655-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21156287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2011 Jan 20;469(7330):314-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21248838</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2011;6(5):e20041</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21625383</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2011 Jun 10;145(6):926-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21663795</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2012 Jan 20;148(1-2):349-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22265420</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Cancer. 2011;11:529</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22208948</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Immunopharmacol. 2012 May;13(1):93-100</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22446296</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2012 Aug 10;337(6095):730-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22855427</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2012 Aug 23;488(7412):522-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22854781</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2012 Aug 23;488(7412):527-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22854777</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2012 Oct 26;151(3):547-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23101625</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2012 Nov 23;338(6110):1080-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23087000</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Stem Cell. 2012 Dec 7;11(6):836-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23217424</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Cell. 2012 Dec 11;22(6):765-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23238013</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Cell. 2013 Feb 11;23(2):238-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23410976</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Mol Med. 2013 Jun;19(6):329-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23540716</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep. 2014 Apr 10;7(1):208-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24656822</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2014;5:5238</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25366259</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2014 Dec 15;20(24):6304-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25338498</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Stem Cell. 2015 Jan 8;16(1):67-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25575080</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Death Differ. 2015 Jul;22(7):1192-202</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25613377</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Adh Migr. 2015;9(4):255-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26207671</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2015 Nov 26;527(7579):525-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26560028</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Stem Cell. 2007 Sep 13;1(3):313-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18371365</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>